Ultimele actualizari :
Stabilitatea si compatibilitatea medicamentelor
Bine ati venit pe site-ul Stabilis. Daca doriti sa primiti ultimele noutati, trimiteti-ne adresa mail.

Pentru intrebari sau comentarii, contactati infostab@stabilis.org
Baze de date  
Bibiografie : 2062
Molecula (substanta activa) : 722
Clasa farmacologica : 40
Stabilitatea solutiilor : 4361
Stabilitatea in amestec : 969
Incompatibilitati : 2636
Denumirea comerciala : 1934
Noutati - Molecula (substanta activa)  
Antiviral Soluţie orală Valacyclovir chlorhydrate 10/12/2015
Diverse Aerosol Histamine HCL 10/12/2015
Citostatic Soluţie orală Hydroxyurea 10/12/2015
Diverse Soluţie orală Hydrocortisone sodium phosphate 09/12/2015
Diverse Soluţie orală Simvastatin 09/12/2015
Diuretic Soluţie orală Furosemid 09/12/2015
Diverse Soluţie orală Pravastatine 09/12/2015
Antibiotic Soluţie orală Doxycycline 09/12/2015
Antimuscarinic Colir Tropicamide 09/12/2015
Antiepileptic Soluţie orală Phenytoin 09/12/2015
Antiparazitar Injectabil Artesunate 10/11/2015
Diverse Injectabil Gelatin 10/11/2015
Simpatomimetic Colir Phenylephrine hydrochloride 24/09/2015
Beta-stimulant Aerosol Formotérol fumarate 24/09/2015
Antihipertensiv Soluţie orală Quinapril 03/09/2015
Antiinflamator Soluţie orală Prednisone 03/09/2015
Antibiotic Soluţie orală Metronidazole benzoate 02/09/2015
Antifungic Injectabil Isavuconazonium sulfate 15/08/2015
Antibiotic Injectabil Ceftolozane / tazobactam 15/08/2015
Antibiotic Injectabil Ceftazidime Avibactam 22/06/2015
Noutati - Bibiografie  
Data de intrare
3819 Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend® SF PH4 oral suspensions. J Pharm Biomed Anal 24/11/2015
3817 A stability study of 25 mg/mL phenylephrine hydrochloride and 5 mg/mL tropicamide eye drops. Gerpac Congress, Giens, France 09/11/2015
3810 Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF. Int J Pharm Compound 21/10/2015
3811 Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures. Int J Pharm Compound 21/10/2015
3804 Physicochemical stability of cabazitaxel and docetaxel solutions. EJHP 21/03/2015
3803 Ceftolozane / tazobactam (Zerbaxa® - Summary of Product Characteristics) Cubist Pharmaceuticals 19/02/2015
3800 Formulation and Clinical Evaluation of Povidone-Iodine Ophthalmic Drop. Iranian J Pharm Res 15/02/2015
3802 Stability of captopril in invert sugar solution J Clin Pharm Ther 15/02/2015
3793 Stability of labetalol hydrochloride in distilled water, simple syrup, and three fruit juices. Drug Intell Clin Pharm 14/02/2015
3796 High dose intravitreal ganciclovir for CMV retinitis: a shelf life and cost comparison study. Br Ophtalmol 14/02/2015
3798 Stability indicating HPLC assay of zidovudine in extemporaneously syrup. Analytical Letter 14/02/2015
3787 Oritavancin diphosphate (Orbactiv®) - Summary of Product Characteristics The Medicines Company 16/01/2015
3771 Pembrolizumab (Keytruda®) - Summary of Product Characteristics Merck Sharp Dohme 22/12/2014
3772 Siltuximab (Sylvant®) - Summary of Product Characteristics Janssen Biotech 22/12/2014
3773 Ramicirumab (Cyramza®) - Summary of Product Characteristics Eli Lilly 22/12/2014
3774 Blinatumomab - (Blincyto®) - Summary of Product Characteristics 22/12/2014
3775 Vincristine sulfate liposome injection (Marqibo®) - Summary of Product Characteristics Talon Therapeutics 22/12/2014
3776 Omecetaxine (Synribo®) - Summary of Product Characteristics Teva Pharmaceuticals 22/12/2014
3777 Stability of ampicillin and amoxicillin in peritoneal dialysis solutions Am J Health-Syst Pharm 22/12/2014
3779 Stability of i.v. admixture containing metoclopramide, diphenhydramine hydrochloride, and dexamethasone sodium phosphate in 0.9% sodium chloride injection Am J Health-Syst Pharm 22/12/2014
3780 Stability of an epidural analgesic admixture containing butorphanol tartrate and ropivacaine hydrochloride EJHP 22/12/2014
3781 Screening for physicochemical incompatibilities of intravenous drugs in intensive care units: the case of monobasic potassium phosphate and furosemide. EJHP 22/12/2014
3782 ­Study of quality and stability of ursodeoxycholic acid formulations for oral pediatric administration Int J Pharm 22/12/2014
3785 Formulation and Stability of an Extemporaneously Compounded Oral Solution of Chlorpromazine HCl J Pain Palliat Care Pharm 22/12/2014
3786 Stability of Melphalan Solution for Intravitreal Injection for Retinoblastoma JAMA Ophtalmology 22/12/2014
3770 Phenylephrine hydrochloride (Vazculep® - Summary of Product Characteristics) Eclat Pharmaceuticals 21/12/2014
3769 Paracatamol (Paracetamol B Braun®) - Résumé des caractéristiques du produit B Braun laboratoire 04/12/2014
3768 Obnituzumab (Gazyvaro®) - Summary of Product Characteristics Roche Products Limited 21/11/2014
3766 Compatibilité de l’acétylcystéine injectable lors de son administration en Y avec d’autres médicaments usuels Pharmactuel 06/11/2014
3767 Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels. Pharmactuel 06/11/2014

Temps de calcul serveur : 100 millisecondes